AVEO Pharmaceuticals (AVEO) Catches Eye: Stock Up 10.4%

ANIP

AVEO Pharmaceuticals, Inc. was a big mover last session, as its shares rose over 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. Yesterday’s rally breaks the trend for the company, as the stock is now trading above the volatile price range of 92 cents to 99 cents in the past one-month time frame.

Over the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

AVEO Pharmaceuticals currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.

Another favorably ranked biomedical stock is ANI Pharmaceuticals, Inc. (ANIP - Free Report) with a Zacks Rank #1 (Strong Buy).

Is AVEO going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>